# Should disease-modifying therapy be discontinued in older patients with stable MS after long-term clinical and radiological stability? Commentary

**Authors:** Anna Karin Hedström

PMC · DOI: 10.1177/13524585251344786 · Multiple Sclerosis (Houndmills, Basingstoke, England) · 2025-05-26

## Full-text entities

- **Diseases:** MS (MESH:D009103)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12159348/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12159348/full.md

## References

4 references — full list in the complete paper: https://tomesphere.com/paper/PMC12159348/full.md

---
Source: https://tomesphere.com/paper/PMC12159348